HTA of Advate in the treatment and the prophylaxis of Hemophilia A: ethical considerations

Research output: Contribution to journalArticlepeer-review

Abstract

The safety, tolerability and efficacy both in terms of prophylaxis and of the therapy of bleeding episodes achievable with Advate® enables us to issue an overall favorable ethical judgment. It is nonetheless advisable that decision makers work towards the creation of procedures of continuity in treatment and towards global care for patients, as well as towards guaranteeing equal access to medicine for all patients.
Original languageEnglish
Pages (from-to)97-102
Number of pages6
JournalItalian Journal of Public Health
Volume9
Publication statusPublished - 2012

Keywords

  • Advate
  • ethical considerations in HTA

Fingerprint

Dive into the research topics of 'HTA of Advate in the treatment and the prophylaxis of Hemophilia A: ethical considerations'. Together they form a unique fingerprint.

Cite this